Loading...
XSTO
SEDANA
Market cap92mUSD
Jul 10, Last price  
8.93SEK
1D
-0.22%
1Q
-3.77%
IPO
52.00%
Name

Sedana Medical AB (publ)

Chart & Performance

D1W1MN
XSTO:SEDANA chart
P/E
P/S
4.43
EPS
Div Yield, %
Shrs. gr., 5y
1.64%
Rev. gr., 5y
7.15%
Revenues
200m
+12.01%
28,113,00032,155,00040,427,70057,896,20071,645,600141,770,000159,152,000122,865,000153,867,000178,754,000200,226,000
Net income
-59m
L+455.03%
-1,205,0001,286,000-3,875,700-6,869,100-16,357,700-27,139,000-57,966,000-73,507,000-59,612,000-10,674,000-59,244,000
CFO
-13m
L+8.58%
0238,000495,600-5,778,900-8,700,200-7,846,000-41,221,000-115,433,000-38,061,000-11,769,000-12,779,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Sedana Medical AB (publ) is a medical technology firm that engineers, promotes, and distributes healthcare devices both within Sweden and across global markets. Its product portfolio includes the Sedaconda ACD-L and Sedaconda ACD, single-use medical tools designed for delivering volatile anesthetics, alongside the Sedaconda Syringe (a 50/60ml syringe) and a Sedaconda ACD starter kit. The company also provides FlurAbsorb and FlurAbsorb-S, active carbon filtration systems engineered to collect residual anesthetic gases discharged by ventilators. Complementing these are the FlurAbsorb accessory kit, which facilitates connecting ventilator exhausts and gas monitors to the filters, and the FlurAbsorb mount, used to secure the filter during anesthetic gas removal. Further offerings encompass the AMG-06 Gas Monitor, which enables ongoing, non-invasive sidestream measurement of carbon dioxide and anesthetic levels in inhaled and exhaled breaths. Additionally, they supply the Sedaconda Filling Adapter, a disposable tool for securely and simply transferring isoflurane from its container to a Sedaconda Syringe, as well as an array of supplemental items like DRYLINE II Water Traps, the WaterLock 2 water trap, Nafion Dryer Tubing, and Respiratory Gas Monitoring Lines. Established in 1999, Sedana Medical AB (publ) maintains its corporate headquarters in Danderyd, Sweden.
IPO date
Jun 21, 2017
Employees
84
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT